Identification of novel targets for breast cancer by exploring gene switches on a genome scale

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Wu, Ming ^a   Liu, Li ^b   Chan, Christina ^a,c  

^a Michigan State University   (United States)

^b Michigan State University   (United States)

^c Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR; TUMOR ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; TACSTD2 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

AGR2 GENE; ARTICLE; BREAST CANCER; CDH1 GENE; CRABP2 GENE; DATA MINING; DSP GENE; ERBB2 GENE; ERBB3 GENE; ESR1 GENE; FXYD3 GENE; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SWITCHING; GENETIC ANALYSIS; GENETIC REGULATION; HUMAN; IRX5 GENE; MICROARRAY ANALYSIS; PREDICTION; RAB25 GENE; SPDEF GENE; TACSTD2 GENE; BREAST TUMOR; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METHODOLOGY; REGULATOR GENE; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DATA MINING; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, SWITCH; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80155138055     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-547     Document Type: Article

References (74)

1. Alon U. An Introduction to Systems Biology: Design Principles of Biological Circuits 2006, Chapman and Hall/CRC, 1.
2. Tyson JJ, Albert R, Goldbeter A, Ruoff P, Sible J. Biological switches and clocks. J R Soc Interface 2008, 5(Suppl 1):S1-8. 2706456, 18522926.
3. Ferrell JE, Xiong W. Bistability in cell signaling: How to make continuous processes discontinuous, and reversible processes irreversible. Chaos 2001, 11:227-236. 10.1063/1.1349894, 12779456.
4. Blake WJ, KAErn M, Cantor CR, Collins JJ. Noise in eukaryotic gene expression. Nature 2003, 422:633-637. 10.1038/nature01546, 12687005.
5. Fraser HB, Hirsh AE, Giaever G, Kumm J, Eisen MB. Noise Minimization in Eukaryotic Gene Expression. PLoS Biol 2004, 2:e137. 10.1371/journal.pbio.0020137, 400249, 15124029.
6. Pomerening JR. Uncovering mechanisms of bistability in biological systems. Curr Opin Biotechnol 2008, 19:381-388. 10.1016/j.copbio.2008.06.009, 18634875.
7. Muller-Hill B. The Lac Operon: A Short History of a Genetic Paradigm 1996, Walter de Gruyter.
8. Smits WK, Kuipers OP, Veening J-W. Phenotypic variation in bacteria: the role of feedback regulation. Nat Rev Micro 2006, 4:259-271.
9. Chang H, Oh P, Ingber D, Huang S. Multistable and multistep dynamics in neutrophil differentiation. BMC Cell Biology 2006, 7:11. 10.1186/1471-2121-7-11, 1409771, 16507101.
10. Das J, Ho M, Zikherman J, Govern C, Yang M, Weiss A, Chakraborty AK, Roose JP. Digital Signaling and Hysteresis Characterize Ras Activation in Lymphoid Cells. Cell 2009, 136:337-351. 10.1016/j.cell.2008.11.051, 2662698, 19167334.
11. Kobayashi T, Chen L, Aihara K. Modeling genetic switches with positive feedback loops. J Theor Biol 2003, 221:379-399. 10.1006/jtbi.2003.3190, 12642114.
12. Warren PB, ten Wolde PR. Chemical models of genetic toggle switches. J Phys Chem B 2005, 109:6812-6823. 10.1021/jp045523y, 16851767.
13. Demir O, Aksan Kurnaz I. An integrated model of glucose and galactose metabolism regulated by the GAL genetic switch. Comput Biol Chem 2006, 30:179-192. 10.1016/j.compbiolchem.2006.02.004, 16679066.
14. Ochab-Marcinek A. Predicting the asymmetric response of a genetic switch to noise. J Theor Biol 2008, 254:37-44. 10.1016/j.jtbi.2008.04.032, 18554612.
15. Yao G, Lee TJ, Mori S, Nevins JR, You L. A bistable Rb-E2F switch underlies the restriction point. Nat Cell Biol 2008, 10:476-482. 10.1038/ncb1711, 18364697.
16. Gardner TS, Cantor CR, Collins JJ. Construction of a genetic toggle switch in Escherichia coli. Nature 2000, 403:339-342. 10.1038/35002131, 10659857.
17. Conrad E, Mayo AE, Ninfa AJ, Forger DB. Rate constants rather than biochemical mechanism determine behaviour of genetic clocks. J R Soc Interface 2008, 5(Suppl 1):S9-15. 2706451, 18426770.
18. Anderson JC, Voigt CA, Arkin AP. Environmental signal integration by a modular AND gate. Mol Syst Biol 2007, 3:133. 1964800, 17700541.
19. Ferrell JE, Machleder EM. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 1998, 280:895-898. 10.1126/science.280.5365.895, 9572732.
20. Shiraishi T, Matsuyama S, Kitano H. Large-Scale Analysis of Network Bistability for Human Cancers. PLoS Comput Biol 2010, 6:e1000851. 10.1371/journal.pcbi.1000851, 2900289, 20628618.
21. Markevich NI, Hoek JB, Kholodenko BN. Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades. The Journal of Cell Biology 2004, 164:353-359. 10.1083/jcb.200308060, 2172246, 14744999.
22. Ozbudak EM, Thattai M, Lim HN, Shraiman BI, Van Oudenaarden A. Multistability in the lactose utilization network of Escherichia coli. Nature 2004, 427:737-740. 10.1038/nature02298, 14973486.
23. Huang S, Eichler G, Bar-Yam Y, Ingber DE. Cell fates as high-dimensional attractor states of a complex gene regulatory network. Phys Rev Lett 2005, 94:128701.
24. Kramer BP, Fussenegger M. Hysteresis in a synthetic mammalian gene network. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:9517-9522. 10.1073/pnas.0500345102, 1172236, 15972812.
25. Muratov AL, Gnedin OY. Modeling the Metallicity Distribution of Globular Clusters. 1002.1325 2010,
26. Nevins JR. The Rb/E2F pathway and cancer. Human Molecular Genetics 2001, 10:699-703. 10.1093/hmg/10.7.699, 11257102.
27. Rubio-Texeira M. A comparative analysis of the GAL genetic switch between not-so-distant cousins: Saccharomyces cerevisiae versus Kluyveromyces lactis. FEMS Yeast Res 2005, 5:1115-1128. 10.1016/j.femsyr.2005.05.003, 16014343.
28. Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M, Abeygunawardena N, Berube H, Dylag M, Emam I, Farne A, Holloway E, Lukk M, Malone J, Mani R, Pilicheva E, Rayner TF, Rezwan F, Sharma A, Williams E, Bradley XZ, Adamusiak T, Brandizi M, Burdett T, Coulson R, Krestyaninova M, Kurnosov P, Maguire E, Neogi SG, Rocca-Serra P, Sansone S-A, Sklyar N, Zhao M, Sarkans U, Brazma A. ArrayExpress update--from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res 2009, 37:D868-872. 10.1093/nar/gkn889, 2686529, 19015125.
29. Sansam CL, Shepard JL, Lai K, Ianari A, Danielian PS, Amsterdam A, Hopkins N, Lees JA. DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint. Genes & Development 2006, 20:3117-3129. 10.1101/gad.1482106, 3206536, 22053279.
30. Pan H-W, Chou H-YE, Liu S-H, Peng S-Y, Liu C-L, Hsu H-C. Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma. Cell Cycle 2006, 5:2676-2687. 10.4161/cc.5.22.3500, 17106265.
31. Ueki T, Nishidate T, Park JH, Lin ML, Shimo A, Hirata K, Nakamura Y, Katagiri T. Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells. Oncogene 2008, 27:5672-5683. 10.1038/onc.2008.186, 18542055.
32. Wang L, Tang H, Thayanithy V, Subramanian S, Oberg AL, Cunningham JM, Cerhan JR, Steer CJ, Thibodeau SN. Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res 2009, 69:9490-9497. 10.1158/0008-5472.CAN-09-2183, 2795036, 19996289.
33. Lev Bar-Or R, Maya R, Segel LA, Alon U, Levine AJ, Oren M. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci USA 2000, 97:11250-11255. 17186, 11016968.
34. Barenco M, Tomescu D, Brewer D, Callard R, Stark J, Hubank M. Ranked prediction of p53 targets using hidden variable dynamic modeling. Genome Biol 2006, 7:R25. 10.1186/gb-2006-7-3-r25, 1557743, 16584535.
35. Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, Dekel E, Yarnitzky T, Liron Y, Polak P, Lahav G, Alon U. Oscillations and variability in the p53 system. Mol Syst Biol 2006, 2. 2006.0033.
36. Batchelor E, Mock CS, Bhan I, Loewer A, Lahav G. Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Mol Cell 2008, 30:277-289. 10.1016/j.molcel.2008.03.016, 2579769, 18471974.
37. Batchelor E, Loewer A, Lahav G. The ups and downs of p53: understanding protein dynamics in single cells. Nat Rev Cancer 2009, 9:371-377. 10.1038/nrc2604, 2892289, 19360021.
38. Pau Ni IB, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, Aina Emran N, Hisham Abdullah N, Syed Hussain SNA. Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context. Pathol Res Pract 2010, 206:223-228. 10.1016/j.prp.2009.11.006, 20097481.
39. Ashman KA, Bird CM, Zepf SE. Detecting bimodality in astronomical datasets. The Astronomical Journal 1994, 108:2348.
40. Collins LC, Botero ML, Schnitt SJ. Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. Am J Clin Pathol 2005, 123:16-20. 10.1309/HCF035N9WK40ETJ0, 15762275.
41. Castles CG, Oesterreich S, Hansen R, Fuqua SAW. Auto-regulation of the estrogen receptor promoter. The Journal of Steroid Biochemistry and Molecular Biology 1997, 62:155-163. 10.1016/S0960-0760(97)00023-X, 9393950.
42. de Souza Rocha Simonini P, Breiling A, Gupta N, Malekpour M, Youns M, Omranipour R, Malekpour F, Volinia S, Croce CM, Najmabadi H, Diederichs S, Sahin O, Mayer D, Lyko F, Hoheisel JD, Riazalhosseini Y. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 2010, 70:9175-9184. 10.1158/0008-5472.CAN-10-1318, 20978187.
43. Harari D, Yarden Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 2000, 19:6102-6114. 10.1038/sj.onc.1203973, 11156523.
44. Naderi A, Liu J, Francis GD. A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer. Int J Cancer 2011, n/a-n/a.
45. Musgrove EA, Sutherland RL. Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 2009, 9:631-643. 10.1038/nrc2713, 19701242.
46. Riggins RB, Schrecengost RS, Guerrero MS, Bouton AH. Pathways to tamoxifen resistance. Cancer Lett 2007, 256:1-24. 10.1016/j.canlet.2007.03.016, 2533271, 17475399.
47. Zhang L, Seitz LC, Abramczyk AM, Liu L, Chan C. cAMP initiates early phase neuron-like morphology changes and late phase neural differentiation in mesenchymal stem cells. Cell Mol Life Sci 2011, 68:863-876. 10.1007/s00018-010-0497-1, 20725762.
48. Ripani E, Sacchetti A, Corda D, Alberti S. Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 1998, 76:671-676. 10.1002/(SICI)1097-0215(19980529)76:5<671::AID-IJC10>3.0.CO;2-7, 9610724.
49. Carafoli E, Brini M. Calcium signalling and disease: molecular pathology of calcium 2007, Springer.
50. Li N, Wang C, Wu Y, Liu X, Cao X. Ca(2+)/calmodulin-dependent protein kinase II promotes cell cycle progression by directly activating MEK1 and subsequently modulating p27 phosphorylation. J Biol Chem 2009, 284:3021-3027.
51. Cubas R, Zhang S, Li M, Chen C, Yao Q. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer 2010, 9:253. 10.1186/1476-4598-9-253, 2946292, 20858281.
52. Kaplan D, Glass L. Understanding Nonlinear Dynamics 1995, Springer.
53. Kappler K, Edwards R, Glass L. Dynamics in high-dimensional model gene networks. Signal Processing 2003, 83:789-798.
54. Mochizuki A. An analytical study of the number of steady states in gene regulatory networks. J Theor Biol 2005, 236:291-310. 10.1016/j.jtbi.2005.03.015, 15885706.
55. Narayanan M, Vetta A, Schadt EE, Zhu J. Simultaneous clustering of multiple gene expression and physical interaction datasets. PLoS Comput Biol 2010, 6:e1000742. 10.1371/journal.pcbi.1000742, 2855327, 20419151.
56. Moreau Y, Aerts S, De Moor B, De Strooper B, Dabrowski M. Comparison and meta-analysis of microarray data: from the bench to the computer desk. Trends Genet 2003, 19:570-577. 10.1016/j.tig.2003.08.006, 14550631.
57. Ramasamy A, Mondry A, Holmes CC, Altman DG. Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray Datasets. PLoS Med 2008, 5.
58. Daigle BJ, Deng A, McLaughlin T, Cushman SW, Cam MC, Reaven G, Tsao PS, Altman RB. Using pre-existing microarray datasets to increase experimental power: application to insulin resistance. PLoS Comput Biol 2010, 6:e1000718. 10.1371/journal.pcbi.1000718, 2845644, 20361040.
59. Lipinski M, Parks DR, Rouse RV, Herzenberg LA. Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc Natl Acad Sci USA 1981, 78:5147-5150. 10.1073/pnas.78.8.5147, 320350, 7029529.
60. Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, Gerhard S, Rasse M, Laimer K. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 2008, 21:186-191.
61. Fong D, Moser P, Krammel C, Gostner JM, Margreiter R, Mitterer M, Gastl G, Spizzo G. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 2008, 99:1290-1295. 10.1038/sj.bjc.6604677, 2570520, 18813308.
62. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M. Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 2006, 12:3057-3063. 10.1158/1078-0432.CCR-05-1961, 16707602.
63. Mühlmann G, Spizzo G, Gostner J, Zitt M, Maier H, Moser P, Gastl G, Zitt M, Müller HM, Margreiter R, Ofner D, Fong D. TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol 2009, 62:152-158.
64. Wang J, Day R, Dong Y, Weintraub SJ, Michel L. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Molecular Cancer Therapeutics 2008, 7:280-285. 10.1158/1535-7163.MCT-07-2003, 18281513.
65. Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM, West M, Nevins JR, Huang AT. Gene expression predictors of breast cancer outcomes. The Lancet 2003, 361:1590-1596.
66. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proceedings of the National Academy of Sciences 2008, 105:20882-20887.
67. Okabe M, Tsukahara Y, Tanaka M, Suzuki K, Saito S, Kamiya Y, Tsujimura T, Nakamura K, Miyajima A. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development 2009, 136:1951-1960. 10.1242/dev.031369, 19429791.
68. Oyama M, Nagashima T, Suzuki T, Kozuka-Hata H, Yumoto N, Shiraishi Y, Ikeda K, Kuroki Y, Gotoh N, Ishida T, Inoue S, Kitano H, Okada-Hatakeyama M. Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer. J Biol Chem 2011, 286:818-829. 10.1074/jbc.M110.156877, 21044952.
69. Scaltriti M, Eichhorn PJ, Cortés J, Prudkin L, Aura C, Jiménez J, Chandarlapaty S, Serra V, Prat A, Ibrahim YH, Guzmán M, Gili M, Rodríguez O, Rodríguez S, Pérez J, Green SR, Mai S, Rosen N, Hudis C, Baselga J. Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients. Proceedings of the National Academy of Sciences 2011, 108:3761-6.
70. Hartigan PM. Algorithm AS 217: Computation of the Dip Statistic to Test for Unimodality. Journal of the Royal Statistical Society. Series C (Applied Statistics) 1985, 34:320-325.
71. Gasch AP, Spellman PT, Kao CM, Carmel-Harel O, Eisen MB, Storz G, Botstein D, Brown PO. Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 2000, 11:4241-4257. 15070, 11102521.
72. Spellman PT, Sherlock G, Zhang MQ, Iyer VR, Anders K, Eisen MB, Brown PO, Botstein D, Futcher B. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell 1998, 9:3273-3297. 25624, 9843569.
73. Abdulrehman D, Monteiro PT, Teixeira MC, Mira NP, Lourenço AB, Dos Santos SC, Cabrito TR, Francisco AP, Madeira SC, Aires RS, Oliveira AL, Sá-Correia I, Freitas AT. YEASTRACT: providing a programmatic access to curated transcriptional regulatory associations in Saccharomyces cerevisiae through a web services interface. Nucleic Acids Res 2010, 39:D136-140. 3013800, 20972212.
74. Newman JRS, Ghaemmaghami S, Ihmels J, Breslow DK, Noble M, DeRisi JL, Weissman JS. Single-cell proteomic analysis of S. cerevisiae reveals the architecture of biological noise. Nature 2006, 441:840-846. 10.1038/nature04785, 16699522.